Legally blind shoppers who tried to use alastin.com with a screen reader may be covered by a proposed class action alleging Alastin Skincare and Galderma failed to make the website accessible. The case seeks a court-ordered fix, not payouts to class members, and there is nothing to file.
This article describes a class action complaint. The statements below are unproven allegations. Alastin Skincare, Inc. and Galderma Laboratories, L.P. have not been found liable, there is no certified class, and nothing to claim at this time. This page is informational and is not legal advice.
Free settlement alerts
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
McLean v. Alastin Skincare, Inc. is a proposed class action filed September 28, 2026 in the U.S. District Court for the Southern District of New York against Alastin Skincare, Inc. and Galderma Laboratories, L.P. It alleges that alastin.com cannot be used by blind and visually impaired shoppers who rely on screen-reading software, in violation of Title III of the Americans with Disabilities Act and New York state and city law. The companies have not been found liable, and the allegations are unproven.
Not as a class member, as the case is framed. The nationwide class seeks only a court order requiring Alastin to make its website accessible, because private plaintiffs under Title III of the ADA can obtain injunctions but not damages. The dollar claims are under New York law and are aimed mainly at the plaintiff and a New York subclass, including a penalty of up to $500 under the New York Civil Rights Law. There is no settlement and nothing to claim.
The complaint proposes a nationwide class of legally blind people in the United States who tried to use alastin.com and were denied equal access because of accessibility barriers, and a New York subclass of legally blind New York residents. No class has been certified.
Yes, according to the complaint. It cites an earlier case, Campbell v. Alastin Skincare, Inc., No. 1:23-cv-03671 (S.D.N.Y.), which it says involved substantially similar accessibility barriers, and alleges the website was never fixed.